Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTC| |TTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGT
End
102866106/102249646 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/940112; hsa-mir-10b/Downstream/182643;
Upstream sequence
aatttggtttctgtttctcacaatggaaataatcctaacaaatacaAGCCTCAATATGTTAGTCTTTTCCTGCAGACTTCTTTCTGATTGATATCACTGT
Downstream sequence
AGCAATGTGAATTTTTCTATGAAATCATGTAAGTTTCTCTCCTTGGAAAAGAGATTAAAAAGCCATACTAGGTTTGGGGTTCCTATCATAAGTGTGTTTG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.